By Megan Stride ( June 18, 2010, 6:22 PM EDT) -- A federal judge has handed a victory to GlaxoSmithKline PLC, Mitsubishi Chemical Corp. and Encysive Pharmaceuticals Inc. in their patent infringement battle with Barr Laboratories over the anti-blood-clotting drug Argatroban, forbidding Barr from producing a generic version of the drug until after its patent has expired....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.